During the past decade, Avail Clinical Research, LLC conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 114 clinical trials were completed, i.e. on average, 134.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 57 clinical trials were completed. i.e. 633.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Avail Clinical Research, LLC" #1 sponsor was "Pfizer" with 36 trials, followed by "Eli Lilly and Company" with 13 trials sponsored, "Gilead Sciences" with 10 trials sponsored, "BioDelivery Sciences International" with 4 trials sponsored and "Ferring Pharmaceuticals" with 4 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avail Clinical Research, LLC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Algorithme Pharma Inc" with 1 trials as a collaborator and "Allergan Sales, LLC" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Avail Clinical Research, LLC" are "Osteoarthritis" (10 trials), "Low Back Pain" (9 trials), "Hepatitis C, Chronic" (5 trials), "Nocturia" (5 trials) and "Osteoarthritis, Knee" (4 trials). Many other conditions were trialed in "Avail Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Avail Clinical Research, LLC" are "Drug" (123 trials), "Biological" (34 trials), "Other" (14 trials), "Device" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (67 trials), "placebo" (8 trials), "Desmopressin" (4 trials), "Buprenorphine" (3 trials) and "Naproxen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Avail Clinical Research, LLC" are 140 trials for "All" genders, 10 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Avail Clinical Research, LLC". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 137 completed trials in Avail Clinical Research, LLC, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Avail Clinical Research, LLC, 22 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 2 trials that are defined as “Not Applicable".